SALSS is back in Stockholm this spring to celebrate 20 years of successful networking and hot topics.

For Evelina Vågesjö, the program aims to create a collaborative stakeholder strategy for Multi-Drug Resistant (MDR) pathogen testing, treatment and policy reform. @ilyapharma @EF_Fellows

The funding round was led by new investors Fåhraeus Startup and Growth (FSG), a Nordic venture capital fund, and European Innovation Council (EIC) Fund.

The TAK1 mechanism is a central biological switch for several central inflammatory processes. By dampening its activity, there is potential to block and delay progression in severe and chronic diseases.

The acquisition of CRST fully aligns with the strategy of @LINKMedical to strengthen its position in the Nordic market, it states.

The alliance will initially focus on areas such as health economics, public diseases, innovation systems, intellectual property rights, and sustainability. @MediconVillage @AstraZeneca @lunduniversity

"This agreement will be very important in creating momentum for Norwegian companies entering the German market," says Arild Kristensen, COO @NorwayHealthTec

If the transaction is approved, it will mean that WntResearch’s current business will cease and be replaced by OPSY’s innovative solution in the insurance medical field.

"They have given us a new and detailed understanding of the mechanisms that normally prevent faulty B cells from attacking tissues in the body," says Olle Kämpe @ScienceAcad_swe

Buloxibutid is a first-in-class angiotensin II type 2 (AT2) receptor agonist that activates an upstream mechanism to drive alveolar repair, resolve fibrosis, and promote pulmonary vascular function.

"I am honored and excited to join LINK Medical as CEO during such a pivotal time," says Anders Göransson @LINKMedical

The team behind NordicRWE believe the possibilities of Real-World Evidence are obvious, but access to and sharing data between the Nordic countries are hurdles that need to be overcome.

"With their investment, we have secured the necessary funds for our registrational Phase 3 trial, which is currently in final scoping reviews with our intended European partner and licensee, Molteni Farmaceutici," says @stiankildal CEO @oncozenge

The investment in Canada will create more than 700 high-skilled jobs, across all areas of the business. @AstraZeneca

This makes Denmark the first Nordic and European country to adopt a performance-based model, where costs are incurred only as long as the gene therapy proves effective over the agreed long-term period. @CSLBehring #GeneTherapy

Preclinical data have shown a marked reduction of endometriotic lesions and pain following treatment with vipoglanstat. @gesynta #endometriosis

The call has aimed to facilitate Nordic networking activities that promote knowledge-sharing and capacity-building relevant to research on the post-COVID condition. @uniofgothenburg @Oslounivsykehus #StatensSerumInstitute

"There is a serious shortage of ultrasound experts in many parts of the world, which has raised concerns of unnecessary interventions and delayed cancer diagnoses. We therefor wanted to find out if AI can complement human experts." @karolinskainst

"This MOU will strengthen formally that relationship, building a bridge between the innovative life science communities in Sweden and California." @BiocomCA @SwedenBIO

"The decision by the FDA is a significant milestone in our efforts to develop a new form of treatment for patients with neuroendocrine tumors," says Jamal El-Mosleh, CEO @EliceraTx